Avalon Trust’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Avalon Trust’s Portfolio HELP Stock Details HELP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.3K	Hold	197	–	–	﹤0.01%	449
2026 Q1	$946	Hold	197	–	–	﹤0.01%	446
2025 Q4	$1.61K	Hold	197	–	–	﹤0.01%	415
2025 Q3	$1.16K	Hold	197	–	–	﹤0.01%	492
2025 Q2	$1.65K	Hold	197	–	–	﹤0.01%	386
2025 Q1	$1.25K	Hold	197	–	–	﹤0.01%	417
2024 Q4	$1.74K	Hold	197	–	–	﹤0.01%	413
2024 Q3	$1.75K	Hold	197	–	–	﹤0.01%	311
2024 Q2	$2.03K	Hold	197	–	–	﹤0.01%	309
2024 Q1	$3.1K	Hold	197	–	–	﹤0.01%	311
2023 Q4	$3.08K	Hold	197	–	–	﹤0.01%	326
2023 Q3	$3.97K	Hold	197	–	–	﹤0.01%	285
2023 Q2	$2.84K	Hold	197	–	–	﹤0.01%	302
2023 Q1	$2.94K	Buy	+197	New	+$3.19K	﹤0.01%	296

Other funds holding HELP

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return

Avalon Trust's HELP Position: Q2 2026 in Review

Avalon Trust held its Helus Pharma Inc. Common Stock (HELP) position steady in Q2 2026 at 197 shares worth $1.3K. The position accounts for ﹤0.01% of the portfolio, ranked #449.

Avalon Trust first reported a position in HELP in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.97K in Q3 2023. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

Avalon Trust held 197 shares of Helus Pharma Inc. Common Stock worth $1.3K as of Q2 2026.
Avalon Trust left its Helus Pharma Inc. Common Stock share count unchanged in Q2 2026.
Helus Pharma Inc. Common Stock made up ﹤0.01% of Avalon Trust's portfolio in Q2 2026, its #449 holding.
Avalon Trust first reported a position in Helus Pharma Inc. Common Stock in Q1 2023 and has held it in 14 quarters since.
Avalon Trust's Helus Pharma Inc. Common Stock position peaked at $3.97K in Q3 2023.
99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Avalon Trust's 13F filing for Q2 2026, filed 6 Aug 2026.